Inaugural lecture to address regulation and its implications for research productivity
LSE's Health and Social Care research centre has been awarded a grant of $600,000 over three years by the Merck Company Foundation. The award represents a significant boost to UK research into pharmaceutical industry competitiveness and policy issues.
To mark the award of the grant, LSE will hold an inaugural lecture on Thursday 16 October, given by leading industry experts, including a keynote speech from Professor Iain Cockburn, School of Management, Boston University and NBER, and chaired by Professor Julian LeGrand, Richard Titmuss Professor of Social Policy at LSE. Professor Cockburn, an internationally renowned expert in health economics, will speak on the dangers posed to the pharmaceutical industry by over-regulation and the threat to research productivity.
The grant made by the Merck Company Foundation, the philanthropic arm of Merck & Co., Inc., is part of the Foundation's Programme on Pharmaceutical Policy Issues (PPPI), which has a remit to increase public awareness and understanding of pharmaceutical policy issues.
Professor Alistair McGuire, professor of health economics at LSE, said: 'We are very pleased to be awarded this grant which enhances our status as a leading research centre in health economics. It is an appropriate time to be looking at the regulation of the pharmaceutical industry and how regulation affects research productivity.
'The Merck Company Foundation's grant will enable us to strengthen our research into some of the key issues facing a highly regulated industry operating in an increasingly challenging environment. We are delighted that as a result of this support, LSE will be able to contribute even more fully to the debate on pharmaceutical industry issues.'
Vincent Lawton, managing director of Merck Sharp & Dohme Limited, Merck & Co., Inc.'s UK subsidiary, commented: 'MSD is a leading commentator on industrial and health policy and this grant will strengthen our ability to contribute to a progressive and research-led debate with stakeholders.'
Professor John van Reenen from the Centre for Economic Performance at LSE will respond to the keynote speech from Professor Iain Cockburn.
For more information or to reserve a press ticket for the event, contact Jessica Winterstein, LSE Press Office, on 020 7955 7060 or email j.Winterstein@lse.ac.uk
At the LSE Health and Social Care Merck Company Foundation inaugural lecture, Professor Iain Cockburn, School of Management, Boston University and NBER, will speak on Regulation, The Evolving Structure of the Pharmaceutical Industry, and Its Implications for Research. Professor Cockburn, an internationally renowned expert in health economics will speak on the dangers posed to the pharmaceutical industry by over-regulation and the threat to research productivity.
The lecture will take place on Thursday 16 October at 6pm in the Shaw Library, Old Building, 6th Floor, Houghton St, London WC2A 2AE. The event is free and open to all with no ticket required.
The Merck Company Foundation, supports proposals from academic 'centres of excellence' to conduct independent research into pharmaceutical policy issues. The Program on Pharmaceutical Policy Issues (PPPI) offers researchers and policymakers the resources to expand the number and capacity of academic centres devoted to the study of these issues by building upon the existing body of academic research.
As a leading, global research-based pharmaceutical company, Merck & Co., Inc., is committed to advancing the knowledge base of pharmaceutical and health policy. The company remains unwavering in its commitment to health, social, policy and environmental concerns that have direct bearing on the well being of people in developed, emerging and developing countries.
LSE Health and Social Care, a research centre in the Department of Social Policy at LSE, was established in 2000. It brought together in one centre LSE Health and the Personal Social Services Research Unit (PSSRU). The Centre's fundamental mission is the production and dissemination of high quality research in health and social care.
14 October 2003